iBio to Participate in Upcoming Healthcare Investor Conferences
Yahoo Finance · Jun 2, 2026 · iBio, Inc. Common Stock (IBIO)
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO) (“iBio” or the “Company”), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&I and Metabolism Conference. Jefferies Glob
Not investment advice. Cached headline, not a full reprint.